What is it about?
The review article entitled “Artificial Intelligence in Drug Discovery and Diagnosis: Challenges, Opportunities, and Strategies” explores the transformative role of artificial intelligence (AI) in pharmaceutical research, drug development, and disease diagnosis. The article discusses how machine learning (ML) and deep learning (DL) technologies can improve the speed, accuracy, and cost-effectiveness of drug discovery and healthcare. The review highlights several important applications of AI, including disease identification, protein structure prediction, drug–protein interaction analysis, toxicity prediction, personalized drug dosing, and rare disease diagnosis. AI-based tools such as AlphaFold, DeepChem, DeepTox, and CURATE. AI demonstrate the potential of computational approaches to identify promising drug candidates, predict adverse effects, and optimize therapeutic interventions. Furthermore, AI-assisted diagnostic systems can support the early detection of diseases such as cancer, diabetes, Alzheimer’s disease, and infectious diseases by analyzing medical images, genetic information, and clinical data. The article also emphasizes the importance of AI in precision medicine, where treatment strategies and drug dosages can be tailored to individual patient characteristics, including genetic profiles and clinical histories. These applications may reduce experimental costs, minimize drug development failures, and decrease reliance on animal testing.
Featured Image
Photo by James Yarema on Unsplash
Why is it important?
Artificial Intelligence (AI) plays a significant role in modern pharmaceutical research, drug discovery, and disease diagnosis. Its ability to analyze large and complex datasets enables researchers to identify potential drug candidates, predict their biological activities, and evaluate their safety more efficiently. AI-based approaches can accelerate different stages of drug development, reduce time and costs, and improve the prioritization of promising therapeutic compounds.
Perspectives
The publication “Artificial Intelligence in Drug Discovery and Diagnosis: Challenges, Opportunities, and Strategies” highlights the growing potential of artificial intelligence (AI) in transforming pharmaceutical research and healthcare. The future prospects of this field are promising, particularly in accelerating drug discovery, improving diagnostic accuracy, and advancing personalized medicine. AI-driven technologies are expected to facilitate the identification of novel therapeutic targets, prediction of drug–target interactions, assessment of toxicity, and optimization of drug candidates, thereby improving the efficiency of pharmaceutical development.
Dr. Akhilesh Kumar Mishra
Read the Original
This page is a summary of: Artificial Intelligence in Drug Discovery and Diagnosis: Challenges, Opportunities, and Strategies, Current Indian Science, April 2026, Bentham Science Publishers,
DOI: 10.2174/012210299x411339260202160840.
You can read the full text:
Contributors
The following have contributed to this page







